Rockefeller Capital Management
TERN

Rockefeller Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Rockefeller Capital Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,381
Closed -$72.8K – 4867
2026
Q1 		$72.8K Buy
1,381
+1,107
+404% +$45.5K ﹤0.01% 3054
2025
Q4 		$11.1K Buy
274
+211
+335% +$4.88K ﹤0.01% 3765
2025
Q3 		$473 Buy
+63
New +$402 ﹤0.01% 4274

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rockefeller Capital Management's TERN Position: Q2 2026 in Review

Rockefeller Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1,381 shares — an estimated $72.8K sold.

Rockefeller Capital Management first reported a position in TERN in Q3 2025 and held it in 3 quarters. The position peaked at $72.8K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Rockefeller Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 1,381 Terns Pharmaceuticals shares in Q2 2026, an estimated $72.8K.
  • Rockefeller Capital Management first reported a position in Terns Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Rockefeller Capital Management's Terns Pharmaceuticals position peaked at $72.8K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.